Aptiv logo

APTV PR A - Aptiv News Story

$162.49 -0.0  -0.0%

Consumer Cyclicals
Large Cap
Market Cap £28.42bn
Enterprise Value £29.39bn
Revenue £11.50bn
Position in Universe th / 7157

Aptiv, Lear join Mexico's effort to ramp up vaccinations at border

Tue 13th July, 2021 3:28am
By Jose Luis  Gonzalez
    CIUDAD JUAREZ, July 12 (Reuters) - Auto part suppliers Aptiv
PLC and Lear Corp turned their plants and parking lots in the
northern Mexico border city of Ciudad Juarez into COVID-19
vaccination centers on Monday, ushering in hundreds of workers
from companies across the city to get shots.
    Mexico is ramping up inoculations in the country's north for
people aged 18 and older after months of restrictions on border
crossings into the United States amid concerns over local
infection rates. 
    Ciudad Juarez was a hotspot of infection early in the
pandemic, prompting worries that the coronavirus was spreading
within the city's numerous factories, including many plants that
serve the U.S. autos sector.  urn:newsml:reuters.com:*:nL1N2C412X 
    Within the first few months of the pandemic, some 20 workers
died from the coronavirus at a single Lear plant.  urn:newsml:reuters.com:*:nL1N2DB03P 
    The company, which makes trim seat covers for Mercedes-Benz
and Ford, on Monday set up rows of chairs inside one of its
plants to begin vaccinating 20,000 workers, their families and
members of the public. 
    Aptiv, an auto technology supplier, began vaccinations in
one of its parking lots, sending health workers onto commuter
buses to give the jabs to workers from Aptiv and other
companies, row by row. The effort is intended to reach 50,000
    Both Lear and Aptiv said the vaccinations, with shots from
Pfizer, were not required for their workers but highly
    "We're doing our part with the government to help bring
health and some normality back to our community, and open the
border," said Vanya Gonzalez, a spokeswoman for Aptiv.

 (Reporting by Jose Luis Gonzalez and Daina Beth Solomon;
editing by Richard Pullin)
 ((daina.solomon@thomsonreuters.com; +52 55 5282 7150;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.